ITERUM THERAPEUTICS PLC
(NASDAQ: ITRM)

Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.

1.570

- (-%)
Range 1.520 - 1.720   (13.16%)
Open -
Previous Close 1.570
Bid Price 1.150
Bid Volume 8
Ask Price 1.180
Ask Volume 12
Volume 106,274
Value -
Remark
Delayed prices. Updated at 26 Apr 2024 23:05.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis